Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, has announced the launch of the SARS-CoV-2 Variant RT-PCR Assays for ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. The ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する